Taubman Institute to appoint six new scholars in 2014
Six new Taubman Scholars -- clinician-scientists selected from among the University of Michigan Medical School faculty -- will be appointed in 2014 by the A. Alfred Taubman Medical Research Institute.
Taubman Scholar grants provide $150,000 per year for three years for these select physician researchers, who combine an active clinical practice with basic laboratory science seeking new treatments and cures for the diseases they treat. The grants are intended to fund the "high risk, high reward" research that often is overlooked by traditional sources of financial support. In the five years since the institute's inception, the research of Taubman Scholars and Taubman Emerging Scholars has led to nearly three dozen human clinical trials of new drugs and therapies for diseases ranging from cancer to muscular dystrophy to ALS.
Prospective scholars must hold an M.D. degree and have until Dec. 1 to complete the application form, which will be vetted by the institute's scientific advisory board, a panel comprised of eminent medical scientsists from outside the university. Click here for complete details and the application form.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.